S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Advaxis Receives Notice of Allowance for Cancer Immunotherapies Patent in Japan|
|Advaxis and the University of Pennsylvania Restructure Their Exclusive License Agreement|
|Advaxis to Present Survival Data of Lm-LLO Cancer Immunotherapies in Recurrent Cervical Cancer and Canine Osteosarcoma at the Society for Immunotherapy of Cancer 29th Annual Meeting|
|Rackspace Accelerates Customers' Journey to the Hybrid Cloud With Increased Security and Scalability|
|Advaxis's ADXS-cHER2 Immunotherapy Demonstrates T-Cell Immune Response in Data Analysis From Canine Osteosarcoma Study|
|Advaxis Provides a Clinical Development Update for Its Immunotherapy, ADXS-HPV, for the Treatment of Cervical Cancer|
|Advaxis Provides Clinical Update for Phase 1/2 Trial of ADXS-HPV Immunotherapy Product Candidate in Anal Cancer|
|Special Opportunities Fund, Inc. Submits Shareholder Proposals to Four Closed-end Funds|
|Advaxis Submits Investigational New Drug Application for ADXS31-142 (ADXS-PSA) for the Treatment of Metastatic Castration Resistant Prostate Cancer|
|Advaxis's Scientific Founder, Dr. Yvonne Paterson, Named One of the PharmaVOICE 100 Most Inspiring People in Life Sciences|
Click above to view more mutual fund data and stats for adx - ADX Energy Ltd.